Why not use the HbA1c as a criterion of dysglycemia in the new definition of the metabolic syndrome? Impact of the new criteria in the prevalence of the metabolic syndrome in a Mediterranean urban population from Southern Europe (IMAP study. Multidisciplinary intervention in primary care)

Diabetes Res Clin Pract. 2011 Aug;93(2):e57-e60. doi: 10.1016/j.diabres.2011.02.024. Epub 2011 Mar 21.

Abstract

We analysed the prevalence of metabolic syndrome (MS) of the new diagnostic criteria and the HbA1c to diagnose dysglycemia. We studied 2006 adults without cardiovascular disease or diabetes. The use of the new criteria and the HbA1c resulted in an increase in the population prevalence of MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cardiovascular Diseases / epidemiology
  • Diabetes Mellitus / epidemiology
  • Europe / epidemiology
  • Female
  • Glycated Hemoglobin / analysis*
  • Humans
  • Male
  • Mediterranean Region / epidemiology
  • Metabolic Syndrome / diagnosis*
  • Metabolic Syndrome / epidemiology
  • Middle Aged
  • Prevalence
  • Urban Population

Substances

  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human